Cambridge Investment Research Advisors
NUS icon

Cambridge Investment Research Advisors’s Nu Skin NUS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,637
Closed -$268K – 3266
2023
Q3 		$268K Buy
+12,637
New +$328K ﹤0.01% 2575
2018
Q4 		– Sell
-4,255
Closed -$351K – 2237
2018
Q3 		$351K Buy
4,255
+746
+21% +$59.3K ﹤0.01% 1689
2018
Q2 		$274K Buy
+3,509
New +$272K ﹤0.01% 1799
2014
Q1 		– Sell
-1,846
Closed -$255K – 1331
2013
Q4 		$255K Sell
1,846
-262
-12% -$30.8K 0.01% 956
2013
Q3 		$202K Buy
+2,108
New +$179K 0.01% 1042

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cambridge Investment Research Advisors's NUS Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 12,637 shares — an estimated $268K sold.

Cambridge Investment Research Advisors first reported a position in NUS in Q3 2013 and held it in 5 quarters. The position peaked at $351K in Q3 2018. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,637 Nu Skin shares in Q4 2023, an estimated $268K.
  • Cambridge Investment Research Advisors first reported a position in Nu Skin in Q3 2013 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Nu Skin position peaked at $351K in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.